In published clinical trials, once weekly cagrilintide has been reported to produce dose dependent body weight reductions in participants with overweight or obesity, and it has also been studied in combination programmes with semaglutide, where trials reported greater weight loss than either component alone
The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed
Our top recommendation is Limitless Life, the go-to source for leading researchers
You can expect to see results over several months, not overnight
Effects typically last 24 to 48 hours
Related research guides Compound guide 10 min BPC-157: A Complete Research Guide BPC-157 (Body Protection Compound 157) is one of the most studied structural research peptides